SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
By P. Rada, A. I. Rojo, S. Chowdhry, Michael T. McMahon, J. Hayes, A. Cuadrado. Molecular and Cellular Biology, 2011
729 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/9b103332ec17714912bb4fb3a1946133b599ef1f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- A. Dinkova-Kostova
- Liam Baird
- J. Hayes
- Donna D. Zhang
- Melba C. Jaramillo
- Q. Ma
- D. Tuveson
- I. I. C. Chio
Citations in the corpus
- Role of nrf2 in oxidative stress and toxicity. (2013, background): “β-TrCP is an adaptor protein for the Cul1-dependent SCF E3 and thereby promotes the ubiquitination and proteasomal degradation of Nrf2 independently of Keap1 (73).”
- The cytoprotective role of the Keap1–Nrf2 pathway (2011, background): “Recent work suggests that GSK3b and the E3 ubiquitin ligase b-TRCP regulate the activity of the Neh6 degron in a Keap1-independent manner (Rada et al. 2011).”
- Nrf2, the Master Regulator of Anti-Oxidative Responses (2017, background): “Neh2 and Neh6 are degrons, which allow Nrf2 targeting to proteasomal degradation by Keap1 (Kelch-like ECH-associated protein1) and β-TrCP (β-transducin repeats-containing proteins) [3].”
- Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease (2015, positive): “Antonio Cuadrado and colleagues first showed that GSK-3β inhibits Nrf2 activity, but identification of the sites in Nrf2 that are phosphorylated by GSK-3 was achieved several years later using two-dimensional electrophoresis and mass spectrometry [75, 76, 299, 300].”
- The emerging role of the Nrf2–Keap1 signaling pathway in cancer (2013, background): “Phosphorylation of the DSGIS motif by GSK-3 increases the ability of β-TrCP to ubiquitinate Nrf2 and promote its rapid turnover (McMahon et al. 2004; Rada et al. 2011; Chowdhry et al. 2013).”
- Hydrogen peroxide sensing, signaling and regulation of transcription factors (2014, background): “Active GSK-3 catalyzes the phosphorylation of NRF2 in the Neh6 domain, forming a phosphodegron that is recognized by the substrate receptor transducin repeat-containing protein (-TrCP) complex, followed by NRF2 ubiquitination and degradation [211].”
- Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. (2012, methodology): “GSK-3 activity antagonises Nrf2 (25), and this has been postulated to entail the formation of a phosphodegron that is recognised by β-TrCP (28).”